Hard to Treat Diseases Inc. (HTDS)

Hard to Treat Diseases Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2009
Period Ending	Sep 30, 2010	Dec 31, 2009
Revenue	6.16	5.39
Cost of Revenue	4.38	3.97
Gross Profit	1.78	1.42
Selling, General & Admin	0.8	0.8
Operating Expenses	0.8	0.8
Operating Income	0.98	0.62
Pretax Income	0.98	0.62
Net Income	0.97	0.62
Net Income to Common	0.97	0.62
Shares Outstanding (Basic)	5,819	4,662
Shares Outstanding (Diluted)	5,819	4,662
EPS (Basic)	0.00	0.00
EPS (Diluted)	0.00	0.00
Free Cash Flow	0.98	0.63
Gross Margin	28.95%	26.29%
Operating Margin	15.94%	11.53%
Profit Margin	15.82%	11.53%
Free Cash Flow Margin	15.89%	11.72%
EBITDA	1.03	0.66
EBITDA Margin	16.65%	12.16%
D&A For EBITDA	0.04	0.03
EBIT	0.98	0.62
EBIT Margin	15.94%	11.53%
Revenue as Reported	6.16	5.39

Source: S&P Global Market Intelligence. Standard template. Financial Sources.